Biotech Research Laboratories

Lee, K. H. Kashiwada, Y. Hashimoto, R Cosentino, L. M. Manak, M. Betulinic acid derivatives and antiviral use (University of North Carolina, at Chapel Hill and Biotech, Research Laboratories). PCX Int. Appl. WO 9639033, December 12, 1996. 

Follow-up on vanished companies and products is difficult, unless they are acquired (Table 2). For example. Biotech Research Laboratories and their peptide nucleic acid oligos (PNAs) were acquired by Boston Biomedica, Inc. Tracking BRL and its specifically targeted PNAs to BBI is simplified by web-page links, which are easy to follow for the reader with a modest knowledge of computer use. 

Users of pipeline databases include pharmaceutical and biotech companies, who assess their own position and that of their competitors by using the databases as a somrce of benchmark measmes. Brokerage firms use the databases to make informed assessments of companies in their portfolios. Academic institutions can use the databases to look for possible partners for com-poimds in their research laboratories. 

The new book Modem Biopharmaceuticals has an impressive list of authors drawn both from world-renowned academic research laboratories and also from the world s leading biotech and pharmaceutical companies. The experts from this coalition of world-class companies, institutes and universities have direct experience of the cutting edge technologies described and understand the various needs, met and unmet This fantastic hne up of authors make it a truly world class book -a four-volume educational platform covering the full spectrum of science from discovery to applications. 

An online directory of biotech research products and services updated weekly. This WWW site offers free searching in the Cold Spring Harbor Lab Manual Source Book database of laboratory products and suppliers. 

Over the past 40 years, capillary electrophoresis (CE) has advanced significantly as a technique for biomolecular characterization. It has not only passed the transition from a laboratory curiosity to a mature instrumental-based method for micro-scale separation, but also emerged as an indispensable tool in the biotech and pharmaceutical industries. CE has become a method of choice in research and development (R D) for molecular characterization, and in quality control (QC) for the release of the therapeutic biomolecules.In the biopharmaceutical industry, more and more CE methods have been validated to meet International Conference on Harmonization (ICH) requirements. In this chapter, we present real industrial examples to demonstrate the role of CE in R D of pharmaceutical products. The focus in this chapter is on method development analytical control for manufacturing and release of therapeutic proteins and antibodies. 

To prepare microarrays requires costly robotics equipment and large-scale sequencing analysis. This is prohibitively expensive for all but the larger research and clinical laboratories and biotech industry for small-scale expression studies or in cases where small numbers of arrays are required, it is not cost-effective. For this reason many researchers opt to acquire premade arrays or amplified cDNA sets from commercial sources. A growing number of specific cDNA subsets are now commercially available as arrays. These include cell-cycle and apoptosis gene arrays. 

Research and development efforts in the pharmaceutical and biotech industries depend critically on patent protection for commercially valuable biological molecules. In this context, patent laws broadly require clear disclosure of molecular function. Deriving this essential functional information is far from trivial [101]. Basic sequence homology studies are already a first step in these critical research efforts. Pattern-based approaches focusing on fundamental structural and functional motifs can valuably focus expensive and lengthy laboratory efforts. The power of these approaches will invariably increase with expansion and improvement of data repositories and associated analysis tools. The U.S. Patent and Trademark Office already welcomes these sorts of in silico studies as valuable adjunct evidence in support of a molecule s functional specification. 

Marine Institute, for his research in the area of Cnidaria intoxications). He gives frequent national and international lectures, is a memher of diverse scientific societies and editorial boards, and is a consultant for pharmaceutical and biotech companies. He is also heading a forensic toxicology laboratory in Belgium at the request of the Ministry of Justice. Dr. Tytgat has been elected as President of the European Section of the International Society on Toxinology (1ST). 

In addition, it has become mandatory for companies or organizations wanting to have their biotech crops approved in Europe to provide reference material as well as a specific detection method. This is then tested and validated by ENGL, the European Network of GMO Laboratories, coordinated by the Community Reference Laboratory of the Joint Research Centre in Ispra, Italy. This is laid down in Regulation 2003/1829/EC ... 

---